Shopping Cart 0
Cart Subtotal
AED 0

Global Drugs for Non-small Cell Lung Cancer Market Analysis 2013-2018 and Forecast 2019-2024

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 10937

Access to Printed Report; No Soft Copy
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : Printed Publication/ Book by Post

Hard Copy License
AED 11671

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 21873

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 21873

Details

Snapshot

The global Drugs for Non-small Cell Lung Cancer market will reach xxx Million USD in 2019 and CAGR xx% 2019-2024. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Drugs for Non-small Cell Lung Cancer by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

Radiofrequency Ablation (RFA)

Radiation Therapy

Chemotherapy

Targeted Therapies

Immunotherapy

Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):

Bristol-Myers Squibb

GlaxoSmithKline

Menarini

Sanofi

Ziopharm Oncology

Alchemia

Amgen

Apotex

BioMarin Pharmaceutical

CellAct Pharma

Cerulean Pharma

Cipla

Cornerstone Pharmaceuticals

Curis

CytRx

Eli Lilly

Exelixis

Fresenius Kabi

Genentech

Hikma Pharmaceuticals

Hospira

Intas Pharmaceuticals

Karyopharm Therapeutics

Kyowa Hakko Kirin

Ligand Pharmaceuticals

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):

Hospital

Clinic

Others

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

Asia-Pacific (China, India, Japan, Southeast Asia etc.)

South America (Brazil, Argentina etc.)

Middle East & Africa (Saudi Arabia, South Africa etc.)

READ MORE

Table Of Content

Scope

Table of Contents

1 Industry Overview

1.1 Drugs for Non-small Cell Lung Cancer Industry

1.1.1 Overview

1.1.2 Development of Drugs for Non-small Cell Lung Cancer

1.2 Market Segment

1.2.1 Upstream

1.2.2 Downstream

1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

2.1 Policy

2.2 Economics

2.3 Sociology

2.4 Technology

3 Drugs for Non-small Cell Lung Cancer Market by Type

3.1 By Type

3.1.1 Radiofrequency Ablation (RFA)

3.1.2 Radiation Therapy

3.1.3 Chemotherapy

3.1.4 Targeted Therapies

3.1.5 Immunotherapy

3.2 Market Size

3.3 Market Forecast

4 Major Companies List

4.Drugs for Non-small Cell Lung Cancer Bristol-Myers Squibb (Company Profile, Sales Data etc.)

4.2 GlaxoSmithKline (Company Profile, Sales Data etc.)

4.3 Menarini (Company Profile, Sales Data etc.)

4.4 Sanofi (Company Profile, Sales Data etc.)

4.5 Ziopharm Oncology (Company Profile, Sales Data etc.)

4.6 Alchemia (Company Profile, Sales Data etc.)

4.7 Amgen (Company Profile, Sales Data etc.)

4.8 Apotex (Company Profile, Sales Data etc.)

4.9 BioMarin Pharmaceutical (Company Profile, Sales Data etc.)

4.10 CellAct Pharma (Company Profile, Sales Data etc.)

4.11 Cerulean Pharma (Company Profile, Sales Data etc.)

4.12 Cipla (Company Profile, Sales Data etc.)

4.13 Cornerstone Pharmaceuticals (Company Profile, Sales Data etc.)

4.14 Curis (Company Profile, Sales Data etc.)

4.15 CytRx (Company Profile, Sales Data etc.)

4.16 Eli Lilly (Company Profile, Sales Data etc.)

4.17 Exelixis (Company Profile, Sales Data etc.)

4.18 Fresenius Kabi (Company Profile, Sales Data etc.)

4.19 Genentech (Company Profile, Sales Data etc.)

4.20 Hikma Pharmaceuticals (Company Profile, Sales Data etc.)

4.21 Hospira (Company Profile, Sales Data etc.)

4.22 Intas Pharmaceuticals (Company Profile, Sales Data etc.)

4.23 Karyopharm Therapeutics (Company Profile, Sales Data etc.)

4.24 Kyowa Hakko Kirin (Company Profile, Sales Data etc.)

4.25 Ligand Pharmaceuticals (Company Profile, Sales Data etc.)

5 Market Competition

5.1 Company Competition

5.2 Regional Market by Company

6 Demand by End Market

6.1 Demand Situation

6.1.1 Demand in Hospital

6.1.2 Demand in Clinic

6.1.3 Demand in Others

6.2 Regional Demand Comparison

6.3 Demand Forecast

7 Region Operation

7.1 Regional Production

7.2 Regional Market

7.3 by Region

7.3.1 North America

7.3.1.1 Overview

7.3.1.2 by Country (U.S., Canada, Mexico)

7.3.2 Europe

7.3.2.1 Overview

7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)

7.3.3 Asia-Pacific

7.3.3.1 Overview

7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)

7.3.4 South America

7.3.4.1 Overview

7.3.4.2 by Country (Brazil, Argentina etc.)

7.3.5 Middle East & Africa

7.3.5.1 Overview

7.3.5.2 by Country (Saudi Arabia, South Africa etc.)

7.4 Regional Import & Export

7.5 Regional Forecast

8 Marketing & Price

8.1 Price and Margin

8.1.1 Price Trends

8.1.2 Factors of Price Change

8.1.3 Manufacturers Gross Margin Analysis

8.2 Marketing Channel

9 Research Conclusion


List Of Figure

Figure Global Drugs for Non-small Cell Lung Cancer Market Growth 2013-2018, by Type, in USD Million

Figure Global Drugs for Non-small Cell Lung Cancer Market Growth 2013-2018, by Type, in Volume

Figure North America Drugs for Non-small Cell Lung Cancer Market Concentration, in 2018

Figure Europe Drugs for Non-small Cell Lung Cancer Market Market Concentration, in 2018

Figure Asia-Pacific Drugs for Non-small Cell Lung Cancer MMarket Concentration, in 2018

Figure South America Drugs for Non-small Cell Lung Cancer Market Concentration, in 2018

Figure Middle East & Africa Drugs for Non-small Cell Lung Cancer Market Concentration, in 2018

Figure Drugs for Non-small Cell Lung Cancer Demand in Hospital , 2013-2018, in USD Million

Figure Drugs for Non-small Cell Lung Cancer Demand in Hospital , 2013-2018, in Volume

Figure Drugs for Non-small Cell Lung Cancer Demand in Clinic , 2013-2018, in USD Million

Figure Drugs for Non-small Cell Lung Cancer Demand in Clinic , 2013-2018, in Volume

Figure Drugs for Non-small Cell Lung Cancer Demand in Others, 2013-2018, in USD Million

Figure Drugs for Non-small Cell Lung Cancer Demand in Others, 2013-2018, in Volume

Figure North America Drugs for Non-small Cell Lung Cancer Market Size and Growth 2013-2018, in USD Million

Figure North America Drugs for Non-small Cell Lung Cancer Market Size and Growth 2013-2018, in Volume

Figure Europe Drugs for Non-small Cell Lung Cancer Market Size and Growth 2013-2018, in USD Million

Figure Europe Drugs for Non-small Cell Lung Cancer Market Size and Growth 2013-2018, in Volume

Figure Asia-Pacific Drugs for Non-small Cell Lung Cancer Market Size and Growth 2013-2018, in USD Million

Figure Asia-Pacific Drugs for Non-small Cell Lung Cancer Market Size and Growth 2013-2018, in Volume

Figure South America Drugs for Non-small Cell Lung Cancer Market Size and Growth 2013-2018, in USD Million

Figure South America Drugs for Non-small Cell Lung Cancer Market Size and Growth 2013-2018, in Volume

Figure Middle East & Africa Drugs for Non-small Cell Lung Cancer Market Size and Growth 2013-2018, in USD Million

Figure Middle East & Africa Drugs for Non-small Cell Lung Cancer Market Size and Growth 2013-2018, in Volume

Figure Marketing Channels Overview


List Of Table

Table Upstream Segment of Drugs for Non-small Cell Lung Cancer

Table Application Segment of Drugs for Non-small Cell Lung Cancer

Table Global Drugs for Non-small Cell Lung Cancer Market 2013-2024, by Application, in USD Million

Table Major Company List of Radiofrequency Ablation (RFA)

Table Major Company List of Radiation Therapy

Table Major Company List of Chemotherapy

Table Major Company List of Targeted Therapies

Table Major Company List of Immunotherapy

Table Global Drugs for Non-small Cell Lung Cancer Market 2013-2018, by Type, in USD Million

Table Global Drugs for Non-small Cell Lung Cancer Market 2013-2018, by Type, in Volume

Table Global Drugs for Non-small Cell Lung Cancer Market Forecast 2019-2024, by Type, in USD Million

Table Global Drugs for Non-small Cell Lung Cancer Market Forecast 2019-2024, by Type, in Volume

Table Bristol-Myers Squibb Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table GlaxoSmithKline Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Menarini Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Menarini (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Sanofi Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Ziopharm Oncology Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Ziopharm Oncology (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Alchemia Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Alchemia (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Amgen Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Apotex Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Apotex (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table BioMarin Pharmaceutical Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of BioMarin Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table CellAct Pharma Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of CellAct Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Cerulean Pharma Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Cerulean Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Cipla Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Cipla (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Cornerstone Pharmaceuticals Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Cornerstone Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Curis Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Curis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table CytRx Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of CytRx (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Eli Lilly Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Exelixis Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Exelixis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Fresenius Kabi Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Fresenius Kabi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Genentech Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Genentech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Hikma Pharmaceuticals Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Hikma Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Hospira Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Hospira (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Intas Pharmaceuticals Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Intas Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Karyopharm Therapeutics Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Karyopharm Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Kyowa Hakko Kirin Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Kyowa Hakko Kirin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Ligand Pharmaceuticals Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Ligand Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Global Drugs for Non-small Cell Lung Cancer Sales Revenue 2013-2018, by Company, in USD Million

Table Global Drugs for Non-small Cell Lung Cancer Sales Revenue Share, by Company, in USD Million

Table Global Drugs for Non-small Cell Lung Cancer Sales Volume 2013-2018, by Company, in Volume

Table Global Drugs for Non-small Cell Lung Cancer Sales Volume Share 2013-2018, by Company, in Volume

Table Major Consumers List and Overview

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table Drugs for Non-small Cell Lung Cancer Demand Forecast 2019-2024, by Application, in USD Million

Table Drugs for Non-small Cell Lung Cancer Demand Forecast 2019-2024, by Application, in Volume

Table Drugs for Non-small Cell Lung Cancer Production 2013-2018, by Region, in USD Million

Table Drugs for Non-small Cell Lung Cancer Production 2013-2018, by Region, in Volume

Table Global Drugs for Non-small Cell Lung Cancer Market 2013-2018, by Region, in USD Million

Table Global Drugs for Non-small Cell Lung Cancer Market Share 2013-2018, by Region, in USD Million

Table Global Drugs for Non-small Cell Lung Cancer Market 2013-2018, by Region, in Volume

Table Global Drugs for Non-small Cell Lung Cancer Market Share 2013-2018, by Region, in Volume

Table North America Drugs for Non-small Cell Lung Cancer Market Size 2013-2018, by Country, in USD Million

Table North America Drugs for Non-small Cell Lung Cancer Market Size 2013-2018, by Country, in Volume

Table Europe Drugs for Non-small Cell Lung Cancer Market Size 2013-2018, by Country, in USD Million

Table Europe Drugs for Non-small Cell Lung Cancer Market Size 2013-2018, by Country, in Volume

Table Asia-Pacific Drugs for Non-small Cell Lung Cancer Market Size 2013-2018, by Country, in USD Million

Table Asia-Pacific Drugs for Non-small Cell Lung Cancer Market Size 2013-2018, by Country, in Volume

Table South America Drugs for Non-small Cell Lung Cancer Market Size 2013-2018, by Country, in USD Million

Table South America Drugs for Non-small Cell Lung Cancer Market Size 2013-2018, by Country, in Volume

Table Middle East & Africa Drugs for Non-small Cell Lung Cancer Market Size 2013-2018, by Country, in USD Million

Table Middle East & Africa Drugs for Non-small Cell Lung Cancer Market Size 2013-2018, by Country, in Volume

Table Drugs for Non-small Cell Lung Cancer Market Forecast 2019-2024, by Region, in USD Million

Table Drugs for Non-small Cell Lung Cancer Market Forecast 2019-2024, by Region, in Volume

Table Price Factors List

Licence Rights

"Single User License
allow one user to read, print, and edit the report

Enterprise License
allow all employees within client's company, to read, print, edit the report"

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Company Profile

Company Profile Title

Snapshot

The global Drugs for Non-small Cell Lung Cancer market will reach xxx Million USD in 2019 and CAGR xx% 2019-2024. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Drugs for Non-small Cell Lung Cancer by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

Radiofrequency Ablation (RFA)

Radiation Therapy

Chemotherapy

Targeted Therapies

Immunotherapy

Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):

Bristol-Myers Squibb

GlaxoSmithKline

Menarini

Sanofi

Ziopharm Oncology

Alchemia

Amgen

Apotex

BioMarin Pharmaceutical

CellAct Pharma

Cerulean Pharma

Cipla

Cornerstone Pharmaceuticals

Curis

CytRx

Eli Lilly

Exelixis

Fresenius Kabi

Genentech

Hikma Pharmaceuticals

Hospira

Intas Pharmaceuticals

Karyopharm Therapeutics

Kyowa Hakko Kirin

Ligand Pharmaceuticals

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):

Hospital

Clinic

Others

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

Asia-Pacific (China, India, Japan, Southeast Asia etc.)

South America (Brazil, Argentina etc.)

Middle East & Africa (Saudi Arabia, South Africa etc.)

READ MORE

Scope

Table of Contents

1 Industry Overview

1.1 Drugs for Non-small Cell Lung Cancer Industry

1.1.1 Overview

1.1.2 Development of Drugs for Non-small Cell Lung Cancer

1.2 Market Segment

1.2.1 Upstream

1.2.2 Downstream

1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

2.1 Policy

2.2 Economics

2.3 Sociology

2.4 Technology

3 Drugs for Non-small Cell Lung Cancer Market by Type

3.1 By Type

3.1.1 Radiofrequency Ablation (RFA)

3.1.2 Radiation Therapy

3.1.3 Chemotherapy

3.1.4 Targeted Therapies

3.1.5 Immunotherapy

3.2 Market Size

3.3 Market Forecast

4 Major Companies List

4.Drugs for Non-small Cell Lung Cancer Bristol-Myers Squibb (Company Profile, Sales Data etc.)

4.2 GlaxoSmithKline (Company Profile, Sales Data etc.)

4.3 Menarini (Company Profile, Sales Data etc.)

4.4 Sanofi (Company Profile, Sales Data etc.)

4.5 Ziopharm Oncology (Company Profile, Sales Data etc.)

4.6 Alchemia (Company Profile, Sales Data etc.)

4.7 Amgen (Company Profile, Sales Data etc.)

4.8 Apotex (Company Profile, Sales Data etc.)

4.9 BioMarin Pharmaceutical (Company Profile, Sales Data etc.)

4.10 CellAct Pharma (Company Profile, Sales Data etc.)

4.11 Cerulean Pharma (Company Profile, Sales Data etc.)

4.12 Cipla (Company Profile, Sales Data etc.)

4.13 Cornerstone Pharmaceuticals (Company Profile, Sales Data etc.)

4.14 Curis (Company Profile, Sales Data etc.)

4.15 CytRx (Company Profile, Sales Data etc.)

4.16 Eli Lilly (Company Profile, Sales Data etc.)

4.17 Exelixis (Company Profile, Sales Data etc.)

4.18 Fresenius Kabi (Company Profile, Sales Data etc.)

4.19 Genentech (Company Profile, Sales Data etc.)

4.20 Hikma Pharmaceuticals (Company Profile, Sales Data etc.)

4.21 Hospira (Company Profile, Sales Data etc.)

4.22 Intas Pharmaceuticals (Company Profile, Sales Data etc.)

4.23 Karyopharm Therapeutics (Company Profile, Sales Data etc.)

4.24 Kyowa Hakko Kirin (Company Profile, Sales Data etc.)

4.25 Ligand Pharmaceuticals (Company Profile, Sales Data etc.)

5 Market Competition

5.1 Company Competition

5.2 Regional Market by Company

6 Demand by End Market

6.1 Demand Situation

6.1.1 Demand in Hospital

6.1.2 Demand in Clinic

6.1.3 Demand in Others

6.2 Regional Demand Comparison

6.3 Demand Forecast

7 Region Operation

7.1 Regional Production

7.2 Regional Market

7.3 by Region

7.3.1 North America

7.3.1.1 Overview

7.3.1.2 by Country (U.S., Canada, Mexico)

7.3.2 Europe

7.3.2.1 Overview

7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)

7.3.3 Asia-Pacific

7.3.3.1 Overview

7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)

7.3.4 South America

7.3.4.1 Overview

7.3.4.2 by Country (Brazil, Argentina etc.)

7.3.5 Middle East & Africa

7.3.5.1 Overview

7.3.5.2 by Country (Saudi Arabia, South Africa etc.)

7.4 Regional Import & Export

7.5 Regional Forecast

8 Marketing & Price

8.1 Price and Margin

8.1.1 Price Trends

8.1.2 Factors of Price Change

8.1.3 Manufacturers Gross Margin Analysis

8.2 Marketing Channel

9 Research Conclusion


List Of Figure

Figure Global Drugs for Non-small Cell Lung Cancer Market Growth 2013-2018, by Type, in USD Million

Figure Global Drugs for Non-small Cell Lung Cancer Market Growth 2013-2018, by Type, in Volume

Figure North America Drugs for Non-small Cell Lung Cancer Market Concentration, in 2018

Figure Europe Drugs for Non-small Cell Lung Cancer Market Market Concentration, in 2018

Figure Asia-Pacific Drugs for Non-small Cell Lung Cancer MMarket Concentration, in 2018

Figure South America Drugs for Non-small Cell Lung Cancer Market Concentration, in 2018

Figure Middle East & Africa Drugs for Non-small Cell Lung Cancer Market Concentration, in 2018

Figure Drugs for Non-small Cell Lung Cancer Demand in Hospital , 2013-2018, in USD Million

Figure Drugs for Non-small Cell Lung Cancer Demand in Hospital , 2013-2018, in Volume

Figure Drugs for Non-small Cell Lung Cancer Demand in Clinic , 2013-2018, in USD Million

Figure Drugs for Non-small Cell Lung Cancer Demand in Clinic , 2013-2018, in Volume

Figure Drugs for Non-small Cell Lung Cancer Demand in Others, 2013-2018, in USD Million

Figure Drugs for Non-small Cell Lung Cancer Demand in Others, 2013-2018, in Volume

Figure North America Drugs for Non-small Cell Lung Cancer Market Size and Growth 2013-2018, in USD Million

Figure North America Drugs for Non-small Cell Lung Cancer Market Size and Growth 2013-2018, in Volume

Figure Europe Drugs for Non-small Cell Lung Cancer Market Size and Growth 2013-2018, in USD Million

Figure Europe Drugs for Non-small Cell Lung Cancer Market Size and Growth 2013-2018, in Volume

Figure Asia-Pacific Drugs for Non-small Cell Lung Cancer Market Size and Growth 2013-2018, in USD Million

Figure Asia-Pacific Drugs for Non-small Cell Lung Cancer Market Size and Growth 2013-2018, in Volume

Figure South America Drugs for Non-small Cell Lung Cancer Market Size and Growth 2013-2018, in USD Million

Figure South America Drugs for Non-small Cell Lung Cancer Market Size and Growth 2013-2018, in Volume

Figure Middle East & Africa Drugs for Non-small Cell Lung Cancer Market Size and Growth 2013-2018, in USD Million

Figure Middle East & Africa Drugs for Non-small Cell Lung Cancer Market Size and Growth 2013-2018, in Volume

Figure Marketing Channels Overview


List Of Table

Table Upstream Segment of Drugs for Non-small Cell Lung Cancer

Table Application Segment of Drugs for Non-small Cell Lung Cancer

Table Global Drugs for Non-small Cell Lung Cancer Market 2013-2024, by Application, in USD Million

Table Major Company List of Radiofrequency Ablation (RFA)

Table Major Company List of Radiation Therapy

Table Major Company List of Chemotherapy

Table Major Company List of Targeted Therapies

Table Major Company List of Immunotherapy

Table Global Drugs for Non-small Cell Lung Cancer Market 2013-2018, by Type, in USD Million

Table Global Drugs for Non-small Cell Lung Cancer Market 2013-2018, by Type, in Volume

Table Global Drugs for Non-small Cell Lung Cancer Market Forecast 2019-2024, by Type, in USD Million

Table Global Drugs for Non-small Cell Lung Cancer Market Forecast 2019-2024, by Type, in Volume

Table Bristol-Myers Squibb Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table GlaxoSmithKline Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Menarini Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Menarini (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Sanofi Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Ziopharm Oncology Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Ziopharm Oncology (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Alchemia Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Alchemia (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Amgen Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Apotex Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Apotex (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table BioMarin Pharmaceutical Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of BioMarin Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table CellAct Pharma Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of CellAct Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Cerulean Pharma Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Cerulean Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Cipla Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Cipla (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Cornerstone Pharmaceuticals Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Cornerstone Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Curis Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Curis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table CytRx Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of CytRx (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Eli Lilly Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Exelixis Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Exelixis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Fresenius Kabi Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Fresenius Kabi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Genentech Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Genentech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Hikma Pharmaceuticals Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Hikma Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Hospira Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Hospira (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Intas Pharmaceuticals Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Intas Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Karyopharm Therapeutics Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Karyopharm Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Kyowa Hakko Kirin Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Kyowa Hakko Kirin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Ligand Pharmaceuticals Overview List

Table Drugs for Non-small Cell Lung Cancer Business Operation of Ligand Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Global Drugs for Non-small Cell Lung Cancer Sales Revenue 2013-2018, by Company, in USD Million

Table Global Drugs for Non-small Cell Lung Cancer Sales Revenue Share, by Company, in USD Million

Table Global Drugs for Non-small Cell Lung Cancer Sales Volume 2013-2018, by Company, in Volume

Table Global Drugs for Non-small Cell Lung Cancer Sales Volume Share 2013-2018, by Company, in Volume

Table Major Consumers List and Overview

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table Drugs for Non-small Cell Lung Cancer Demand Forecast 2019-2024, by Application, in USD Million

Table Drugs for Non-small Cell Lung Cancer Demand Forecast 2019-2024, by Application, in Volume

Table Drugs for Non-small Cell Lung Cancer Production 2013-2018, by Region, in USD Million

Table Drugs for Non-small Cell Lung Cancer Production 2013-2018, by Region, in Volume

Table Global Drugs for Non-small Cell Lung Cancer Market 2013-2018, by Region, in USD Million

Table Global Drugs for Non-small Cell Lung Cancer Market Share 2013-2018, by Region, in USD Million

Table Global Drugs for Non-small Cell Lung Cancer Market 2013-2018, by Region, in Volume

Table Global Drugs for Non-small Cell Lung Cancer Market Share 2013-2018, by Region, in Volume

Table North America Drugs for Non-small Cell Lung Cancer Market Size 2013-2018, by Country, in USD Million

Table North America Drugs for Non-small Cell Lung Cancer Market Size 2013-2018, by Country, in Volume

Table Europe Drugs for Non-small Cell Lung Cancer Market Size 2013-2018, by Country, in USD Million

Table Europe Drugs for Non-small Cell Lung Cancer Market Size 2013-2018, by Country, in Volume

Table Asia-Pacific Drugs for Non-small Cell Lung Cancer Market Size 2013-2018, by Country, in USD Million

Table Asia-Pacific Drugs for Non-small Cell Lung Cancer Market Size 2013-2018, by Country, in Volume

Table South America Drugs for Non-small Cell Lung Cancer Market Size 2013-2018, by Country, in USD Million

Table South America Drugs for Non-small Cell Lung Cancer Market Size 2013-2018, by Country, in Volume

Table Middle East & Africa Drugs for Non-small Cell Lung Cancer Market Size 2013-2018, by Country, in USD Million

Table Middle East & Africa Drugs for Non-small Cell Lung Cancer Market Size 2013-2018, by Country, in Volume

Table Drugs for Non-small Cell Lung Cancer Market Forecast 2019-2024, by Region, in USD Million

Table Drugs for Non-small Cell Lung Cancer Market Forecast 2019-2024, by Region, in Volume

Table Price Factors List

"Single User License
allow one user to read, print, and edit the report

Enterprise License
allow all employees within client's company, to read, print, edit the report"

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS